Interferons, interferon‐like cytokines, and their receptors

By S. Pestka, Christopher D. Krause, Mark Walter. Immunological Reviews, 2004

1,814 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/1af536fcb0f05325966f9013b7dfaffc140374b9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

In Oncology

Citations in the corpus

Mechanisms of type-I- and type-II-interferon-mediated signalling (2005, background): “The IFN family includes two main classes of related cytokines: type I IFNs and type II IF”
Interferon signalling network in innate defence (2006, background): “Among these ligands, it was reported that human IFN-α subtypes contain 12 distinct proteins (Pestka, 2000; Pestka et al., 2004).”
Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo (2006, background): “of genes termed ISGs, leading to induction of the antiviral state and other IFN functions (8, 28).”
Immunomodulatory functions of type I interferons (2012, background): “In humans and mice, the type I IFN family is composed of 16 members, namely 12 IFNα subtypes, IFNβ, IFNɛ, IFNκ and IFN”
IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo (2008, background): “IFNs are glycosylated while others are not [4,5,9,10].”
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes (2012, background): “There are three types of IFNs, namely type I (composed of a, b, k, e and o subtypes), type II (a single IFNg) and type III (IFN ; also called IL28 and IL29), which are distinguished by having distinct genetic loci, amino acid sequence homology and specific cognate receptors (3).”
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 (2020, result): “Very similar results were obtained with the corresponding DNA sequences ( 37 , 39 ).”
Interferons at age 50: past, current and future impact on biomedicine (2007, background): “Although type I IFNs have qualitative and quantita tive differences in their antiviral and other actions [33] [34] [35] [36] [37] [38] [39] [40] , the reason for origin and maintenance through evolu tion of these related proteins is unknown.”